B7H3 (CD276) (NM_025240) Human Mass Spec Standard
Specifications
| Product Data | |
| Tag | C-Myc/DDK |
|---|---|
| Species | Human |
| Expression Host | HEK293 |
| Expression cDNA Clone or AA Sequence | RC215291 |
| Predicted MW | 33.6 kDa |
| Protein Sequence | |
| Purity | > 80% as determined by SDS-PAGE and Coomassie blue staining |
| Concentration | >0.05 µg/µL as determined by microplate BCA method |
| Labeling Method | Labeled with U- 13C6, 15N4-L-Arginine and U- 13C6, 15N2-L-Lysine |
| Buffer | 25 mM Tris-HCl, 100 mM glycine, pH 7.3 |
| Storage | Store at -80°C. Avoid repeated freeze-thaw cycles. |
| Stability | Stable for 3 months from receipt of products under proper storage and handling conditions. |
| Shipping | Dry Ice |
| Reference Data | |
| RefSeq | NP_079516 |
| RefSeq Size | 2765 |
| RefSeq ORF | 948 |
| Synonyms | 4Ig-B7-H3; B7-H3; B7H3; B7RP-2 |
| Locus ID | 80381 |
| UniProt ID | Q5ZPR3 |
| Cytogenetics | 15q24.1 |
| Summary | The protein encoded by this gene belongs to the immunoglobulin superfamily, and thought to participate in the regulation of T-cell-mediated immune response. Studies show that while the transcript of this gene is ubiquitously expressed in normal tissues and solid tumors, the protein is preferentially expressed only in tumor tissues. Additionally, it was observed that the 3' UTR of this transcript contains a target site for miR29 microRNA, and there is an inverse correlation between the expression of this protein and miR29 levels, suggesting regulation of expression of this gene product by miR29. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. provided by RefSeq, Sep 2011 |
| Protein Families | Druggable Genome, Transmembrane |
| Protein Pathways | Cell adhesion molecules (CAMs) |
Reviews
Documents
| FAQs |
| SDS |
Resources
| Recombinant Protein Resources |
Other "B7H3" proteins (9)
| SKU | Description | Size | Price | |
|---|---|---|---|---|
| LC410803 | Lyophilized CD276 HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug |
$206.00
|
|
| LC422539 | Lyophilized CD276 HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug |
$206.00
|
|
| LC425464 | Lyophilized CD276 HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug |
$206.00
|
|
| LY410803 | Transient overexpression lysate of CD276 molecule (CD276), transcript variant 2 (as WB positive control) | 100 ug |
$436.00
|
|
| LY422539 | Transient overexpression lysate of CD276 molecule (CD276), transcript variant 1 (as WB positive control) | 100 ug |
$665.00
|
|
| LY425464 | Transient overexpression lysate of CD276 molecule (CD276), transcript variant 1 (as WB positive control) | 100 ug |
$436.00
|
|
| TP315291 | Recombinant protein of human CD276 molecule (CD276), transcript variant 2, 20 µg | 20 ug |
$737.00
|
|
| TP700270 | Purified recombinant protein of human CD276 molecule (CD276), transcript variant 1, with C-terminal DDK/His tag, expressed in human cells, 20 µg | 20 ug |
$900.00
|
|
| TP723935 | Recombinant human B7-H3 protein with C-terminal mouse Fc and 6×His tag | 100 ug |
$795.00
|
|
Citations
Zhou, Zhao
Cancer Manag Res (2019) 11, 10205-10214 DOI: 10.2147/CMAR.S222224
Related Products
- Price:
- Actual Price:
Welcome to OriGene AI!
I'm your AI-powered guide to everything OriGene.
Ask me anything:
- Product specs
- Ordering help
- Technical questions
- How to find exactly what your experiment needs
Prefer a live agent? Connect with us by clicking the green chat icon, as seen in the image below or email our team at custsupport@origene.com.